JFL Life Sciences Limited (NSE:JFLLIFE)
9.40
0.00 (0.00%)
At close: Apr 28, 2026
JFL Life Sciences Market Cap
JFL Life Sciences has a market cap or net worth of 310.16 million as of April 29, 2026. Its market cap has decreased by -57.66% in one year.
Market Cap
310.16M
Enterprise Value
400.28M
Revenue
744.78M
Ranking
n/a
PE Ratio
11.74
Stock Price
9.40
Market Cap Chart
Since September 8, 2022, JFL Life Sciences's market cap has decreased from 731.40M to 310.16M, a decrease of -57.59%. That is a compound annual growth rate of -21.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 310.16M | -24.80% |
| Dec 31, 2025 | 412.44M | -59.35% |
| Dec 30, 2024 | 1.01B | 122.29% |
| Dec 29, 2023 | 456.44M | 22.06% |
| Dec 30, 2022 | 373.95M | -48.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gujarat Terce Laboratories | 298.10M |
| Rekvina Laboratories | 277.29M |
| Walpar Nutritions | 347.45M |
| Murae Organisor | 353.20M |
| Welcure Drugs and Pharmaceuticals | 358.42M |
| Deccan Health Care | 267.75M |
| Panjon | 405.60M |
| Hamps Bio | 222.16M |